New Horizon Investment Advisors
Advantech, Redview target $1.5b for China deals
Advantech Capital and Redview Capital – parallel entities formed following the restructuring of Chinese GP New Horizon Capital – are seeking a combined $1.5 billion for their latest funds.
PE investors back $402m Sinovac take-private
A consortium of private equity investors has agreed to privatize US-listed Chinese biopharmaceutical player Sinovac Biotech in a deal worth $401.8 million, bringing a contentious bidding process to an end.
Asia-IO, Redview buy Source Photonics from US GP
Asia-IO Advisors – a PE firm set up by Denis Tse, formerly of Lockheed Martin Investment Management, and Michael Prahl, a professor at business school INSEAD – has teamed up with New Horizon Capital spin-out Redview Capital to buy US communications...
Princeling funds: Who's your daddy?
Another month, another princeling fund. Okay, so they're not that prolific but there is a familiarity to PE platforms built upon the shoulders of Chinese leaders' offspring in terms of the nature of their emergence.
Son of ex-China politburo member raises PE fund
The son of He Guoqiang, until last year the member of China's politburo standing committee responsible for policing corruption in government, has established a private equity firm called Nepoch Capital.
China’s NSSF assets top $178b in 2012
China’s National Council for Social Security Fund (NSSF) reported a 7% investment return in 2012, its best performance in three years, as total assets under management topped RMB1 trillion ($178 billion) for the first time.
The debt deadline: Japans's SMEs at a crossroads
Japan’s Debt Moratorium Law, seen by some industry participants as an impediment to PE deal flow in the last three year, is set to expire at the end of March. Does this spell new opportunities for the industry?
NSSF nears $3.6b private equity investments
The National Council for Social Security Fund (NSSF) announced that it had committed RMB22.6 billion ($3.6 billion) to 16 venture capital and private equity funds as of mid-September.
China biotech: Elusive innovation?
PE and VC investors want to leverage China’s rapidly growing biotech industry, but few firms have a proven ability to commercialize their innovations in drug development. Change will come, gradually.
CDH, CITIC, New Horizon buy Luye Pharma from MBK
CDH Capital, Citic Private Equity and New Horizon Capital, three of China's largest private equity firms, have bought Luye Pharma from Korea-based MBK Partners.
Wen Jiabao's son appointed chairman of China Satellite
Winston Wen Yunsong, son of Chinese Premier Wen Jiabao and co-founder of New Horizon Capital, has been named chairman of state-owned China Satellite Communications Corp (SATCOM).
PE succession planning: Continuity issues
Asia’s private equity industry may not be old, but it is still volatile. Firms that fail to address succession planning – due to staff turnover if not staff ages – risk losing the confidence of LPs.
New Horizon-backed Sinovel faces legal action over alleged IP theft
Sinovel Wind Group, a Chinese turbine manufacturer part-owned by New Horizon Capital, faces legal action from American Superconductor Corp. (AMSC) after one of its employees was jailed for stealing intellectual property and selling it to the Chinese firm....
Japanese GPs prepare for a smaller future
Consolidation is in the cards as Japan’s private equity industry focuses on mid-cap plays rather than buyouts
New Horizon targets fourth fund worth $750m
New Horizon Capital is looking to raise a new fund just over a year since closing its previous vehicle and without the involvement of co-founder Winston Wen Yunsong, son of Chinese Premier Wen Jiabao.
Changing perceptions on Japanese private equity
There is no hiding from the fact that foreign institutional investors have developed a negative view on the current prospects for Japan’s private equity and venture capital industry, which in turn has made a significant impact domestic GPs’ abilities...
Cleary Gottlieb Steen & Hamilton opening Hong Kong practice
New York-headquartered law firm Cleary Gottlieb Steen & Hamilton LLP (CGSH), has appointed Freeman Chan as a partner, starting in early 2011 concurrent with the launch of the firm’s new Hong Kong law practice.
Wen out of New Horizon as Sihuan Pharma pre-IPO deal nixed
Leading Chinese PE firm New Horizon has confirmed that its co-founder Winston Wen Yunsong, son of PRC Premier Wen Jiabao, left the company at an unspecified date and has been working since last year for an arm of China Aerospace Science & Technology Corp.,...
Consortium to invest $279.5 million into Tangshan Jidong Cement
A consortium of investors including Singapore's GIC, New Horizon, and US multi-strategy firm Siguler Guff,plans to invest more than RMB1.9 billion ($279.5 million) into Tangshan Jidong Cement Co., a PRC cement business, to take a 10% stake in the Shenzhen-listed...
New Horizon closes Fund III
Track record, platform, name value show in result
New Horizon closes Fund III
New Horizon Investment Advisors, the Beijing-headquartered growth capital GP set up in 2005 as a JV between Temasek Holdings and SBI Holdings, has closed its New Horizon Capital III fund at $750 million, a New Horizon director confirmed to AVCJ.
New Horizon rumored at $1 billion
Co-founded by the Chinese Prime Minister’s son, Wen Yunsong, PRC-focused private equity fund New Horizon Capital is fundraising for its third fund, originally targeting $500 million but now rumored to be looking at hitting the $1 billion mark.